SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,000 | -54.5% | 38,453 | -26.1% | 0.00% | – |
| Q1 2020 | $22,000 | +69.2% | 52,061 | +36.7% | 0.00% | – |
| Q4 2019 | $13,000 | -60.6% | 38,084 | -17.0% | 0.00% | – |
| Q3 2019 | $33,000 | 0.0% | 45,881 | +2.0% | 0.00% | – |
| Q2 2019 | $33,000 | -13.2% | 44,981 | +45.2% | 0.00% | – |
| Q1 2019 | $38,000 | +171.4% | 30,981 | -8.7% | 0.00% | – |
| Q4 2018 | $14,000 | -75.9% | 33,916 | +17.2% | 0.00% | – |
| Q3 2018 | $58,000 | -49.1% | 28,938 | -46.3% | 0.00% | -100.0% |
| Q2 2018 | $114,000 | -29.2% | 53,844 | -9.2% | 0.00% | -50.0% |
| Q1 2018 | $161,000 | +126.8% | 59,270 | +208.7% | 0.00% | – |
| Q4 2017 | $71,000 | – | 19,200 | +14783.7% | 0.00% | – |
| Q2 2017 | $0 | – | 129 | +396.2% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 26 | -99.8% | 0.00% | -100.0% |
| Q4 2016 | $52,000 | -27.8% | 14,433 | -12.2% | 0.00% | 0.0% |
| Q3 2016 | $72,000 | – | 16,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,600,000 | $1,092,000 | 1.15% |
| BVF INC/IL | 2,287,860 | $951,000 | 0.12% |
| Eventide Asset Management | 2,265,455 | $942,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 400,140 | $166,000 | 0.04% |
| RP Management, LLC | 129,517 | $54,000 | 0.04% |
| Palo Alto Investors LP | 1,162,473 | $483,000 | 0.03% |
| NEA Management Company, LLC | 1,298,274 | $539,000 | 0.02% |
| Rhenman & Partners Asset Management AB | 377,244 | $157,000 | 0.02% |
| GREAT POINT PARTNERS LLC | 317,962 | $132,000 | 0.02% |
| Vivo Capital, LLC | 195,474 | $81,000 | 0.01% |